SCLP — Scancell Holdings Balance Sheet
0.000.00%
Last trade - 00:00- £101.18m
- £100.56m
- £4.71m
Annual balance sheet for Scancell Holdings, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.
2021 April 30th | R2022 April 30th | R2023 April 30th | 2024 April 30th | 2025 April 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 41.1 | 28.7 | 19.9 | 14.8 | 16.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.84 | 3.64 | 4.28 | 5.85 | 3.18 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 44.7 | 32.4 | 24.6 | 21.9 | 20.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.975 | 2.74 | 2.25 | 1.71 | 0.847 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 49.1 | 35.1 | 26.9 | 23.6 | 23.1 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.29 | 6.65 | 7.97 | 6.39 | 26.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 29.6 | 33.7 | 36.5 | 27.1 | 26.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 19.5 | 1.39 | -9.65 | -3.5 | -3.83 |
| Total Liabilities & Shareholders' Equity | 49.1 | 35.1 | 26.9 | 23.6 | 23.1 |
| Total Common Shares Outstanding |